-
2
-
-
63249118690
-
ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study
-
Schröder FH, Hugosson J, Roobol MJ, et al. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360(13):1320-1328.
-
(2009)
N Engl J Med
, vol.360
, Issue.13
, pp. 1320-1328
-
-
Schröder, F.H.1
Hugosson, J.2
Roobol, M.J.3
-
3
-
-
44049096242
-
Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: A surveillance modeling approach
-
DOI 10.1177/0272989X07312719
-
Etzioni R, Gulati R, Falcon S, Penson DF. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Med Decis Making. 2008;28(3):323-331. (Pubitemid 351713299)
-
(2008)
Medical Decision Making
, vol.28
, Issue.3
, pp. 323-331
-
-
Etzioni, R.1
Gulati, R.2
Falcon, S.3
Penson, D.F.4
-
4
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300.
-
(2010)
CA Cancer J Clin
, vol.60
, Issue.5
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
5
-
-
79955705831
-
SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer
-
Bill-Axelson A, Holmberg L, Ruutu M, et al.; SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2011; 364(18):1708-1717.
-
(2011)
N Engl J Med
, vol.364
, Issue.18
, pp. 1708-1717
-
-
Bill-Axelson, A.1
Holmberg, L.2
Ruutu, M.3
-
6
-
-
70349941075
-
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005
-
Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst. 2009;101(19):1325-1329.
-
(2009)
J Natl Cancer Inst
, vol.101
, Issue.19
, pp. 1325-1329
-
-
Welch, H.G.1
Albertsen, P.C.2
-
7
-
-
84555215993
-
United States life tables, 2007
-
Arias E. United States life tables, 2007. Natl Vital Stat Rep. 2011;59(9): 1-60.
-
(2011)
Natl Vital Stat Rep
, vol.59
, Issue.9
, pp. 1-60
-
-
Arias, E.1
-
8
-
-
67649993396
-
Future of cancer incidence in the United States: Burdens upon an aging, changing nation
-
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758-2765.
-
(2009)
J Clin Oncol
, vol.27
, Issue.17
, pp. 2758-2765
-
-
Smith, B.D.1
Smith, G.L.2
Hurria, A.3
Hortobagyi, G.N.4
Buchholz, T.A.5
-
9
-
-
0037812658
-
The influence of finasteride on the development of prostate cancer
-
DOI 10.1056/NEJMoa030660
-
Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. (Pubitemid 36859473)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.3
, pp. 215-224
-
-
Thompson, I.M.1
Goodman, P.J.2
Tangen, C.M.3
Lucia, M.S.4
Miller, G.J.5
Ford, L.G.6
Lieber, M.M.7
Cespedes, R.D.8
Atkins, J.N.9
Lippman, S.M.10
Carlin, S.M.11
Ryan, A.12
Szczepanek, C.M.13
Crowley, J.J.14
Coltman Jr., C.A.15
-
10
-
-
77950498003
-
Effect of dutasteride on the risk of prostate cancer
-
REDUCE Study Group
-
Andriole GL, Bostwick DG, Brawley OW, et al. REDUCE Study Group. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362(13): 1192-1202.
-
(2010)
N Engl J Med
, vol.362
, Issue.13
, pp. 1192-1202
-
-
Andriole, G.L.1
Bostwick, D.G.2
Brawley, O.W.3
|